Psychological Burden And Quality Of Life Impairment In Patients With Chronic & Recurrent Dermatophytosis.
DOI:
https://doi.org/10.69980/ajpr.v28i2%20(Part%20A).958Keywords:
Quality of life (QoL), Chronic and recurrent dermatophytosis, DLQI, Skindex-16Abstract
Background: Dermatophytosis, when chronic or recurrent, poses a substantial burden on patients' psychosocial quality of life.
Aim: To assess impact on quality of life in patients with chronic & recurrent dermatophytosis using DLQI & Skindex-16 scores.
Methodology: The study included 150 patients over the age of 16 who had chronic and recurrent dermatophytosis. A thorough history was obtained, and examination findings were entered into a proforma. Patients were made to fill Skindex-16 and DLQI in English and local languages. Skindex-16 scores (0–96) were converted to a linear scale from 0 to 100. Statistical analysis was done using SPSS version 26.
Results: Data of 150 patients was analysed. Mean DLQI score was12.18 ± 5.13 with main domain affected being "symptoms and feelings," followed by "work and school”. 54% of the patients with CRD had a "very large effect" on their quality of life (DLQI score 11–20). Mean Skindex-16 score was 67.44 ± 21.35. According to Skindex-16, "Emotions" was the most impacted domain, followed by "Function" and then "Symptom." Higher DLQI scores were seen in patients belonging to age group 30-50. (χ2 = 33.99, p < .001). Occupation was also found to be a risk factor for higher DLQI scores with homemakers constituting the major sub-group. (χ2 = 25.183, p < .01). Higher mean percentage Skindex-16 scores were observed in younger age group (18-30 years)(p <.05). Mean percentage emotion score was significantly higher in females. (p < .05). Functional impairment was noticed in younger population. (p<0.05)
Conclusion: CRD can cause a significant reduction in quality of life. Patients should be treated by a multidisciplinary team that includes psychiatrists and psychologists.
References
1.Jartarkar SR, Patil A, Goldust Y, Cockerell CJ, Schwartz RA, Grabbe S, et al. Pathogenesis, immunology and management of dermatophytosis. J Fungi (Basel) [Internet]. 2021;8(1):39. Available from: http://dx.doi.org/10.3390/jof8010039
2.Dogra S, Uprety S. The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive? Indian Dermatol Online J [Internet]. 2016;7(2):73. Available from: http://dx.doi.org/10.4103/2229-5178.178100
3.Mushtaq S, Faizi N, Amin SS, Adil M, Mohtashim M. Impact on quality of life in patients with dermatophytosis. Australas J Dermatol [Internet]. 2020;61(2). Available from: http://dx.doi.org/10.1111/ajd.13191
4.Padhiyar J, Patel N, Patel A, Chhebber A, Patel B, Patel T. Psychosocial and financial impact of disease among patients of dermatophytosis, a questionnaire-based observational study. Indian Dermatol Online J [Internet]. 2020;11(3):373. Available from: http://dx.doi.org/10.4103/idoj.idoj_331_19
5.Anushree LS, Anupama YG, Praveena C, Dadapeer HJ. Dermatology quality of life and psychological morbidity in patients with chronic dermatophytosis. J Pak Assoc Dermatol [Internet]. 2023 [cited 2025 Feb 5];33(1):84–90. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2036
6.Narang T, Bhattacharjee R, Singh S, Jha K, Kavita, Mahajan R, et al. Quality of life and psychological morbidity in patients with superficial cutaneous dermatophytosis. Mycoses [Internet]. 2019;62(8):680–5. Available from: http://dx.doi.org/10.1111/myc.12930
7.Meneguin S, de Souza Matos TD, Pollo CF, Garuzi M, Miot HA, de Oliveira C. Psychometric characteristics of DLQI-BRA and Skindex-16 to measure the impact of dermatological diseases on quality of life in Brazilian patients. PLoS One [Internet]. 2021;16(8):e0254882. Available from: http://dx.doi.org/10.1371/journal.pone.0254882
8.Baskaran N, Arunima A, Shah S, Narang T, Kumaran MS. Psychological Morbidity in Chronic Dermatological Disorders: A Review. Indian Dermatol Online J. 2025 Apr 17;16(3):381-388. doi: 10.4103/idoj.idoj_458_24. PMID: 40395584; PMCID: PMC12088501.
9.Lakum M. The Hidden Struggle: Understanding the Psychosocial Impact of Dermatological Diseases. Indian J Postgrad Dermatol. 2024;2:74-9. doi: 10.25259/IJPGD_23_2024
10.Lakshmanan A, Ganeshkumar P, Mohan SR, Hemamalini M, Madhavan R. Epidemiological and clinical pattern of dermatomycoses in rural India. Indian J Med Microbiol [Internet]. 2015;33:S134–6. Available from: http://dx.doi.org/10.4103/0255-0857.150922
11.Vyas J, Johns JR, Ali FM, Ingram JR, Salek S, Finlay AY. A systematic review of 207 studies describing validation aspects of the Dermatology Life Quality Index. Acta Derm Venereol [Internet]. 2024;104:adv41120. Available from: http://dx.doi.org/10.2340/actadv.v104.41120
12.Abramson LY, Seligman MEP, Teasdale JD. Learned helplessness in humans: critique and reformulation. Journal of Abnormal Psychology. 1978;87(1):49-74.
13.Seligman MEP. Helplessness: On depression, development, and death. San Francisco (CA): W.H. Freeman and Company; 1975
14.Verma SB, Panda S, Nenoff P, Singal A, Rudramurthy SM, Uhrlass S, et al. The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features. Indian J Dermatol Venereol Leprol [Internet]. 2021;87(2):154–75. Available from: http://dx.doi.org/10.25259/IJDVL_301_20
15.Altabe MN, Thompson JK. Body image: a cognitive self-schema construct? Cognit Ther Res. 1996 Apr;20(2):171-93. doi: 10.1007/BF02229260.
16.Cash TF. The body image workbook: an 8-step program for learning to like your looks. Oakland (CA): New Harbinger Publications; 2008.
17.Kent G, Keohane S. Social anxiety and disfigurement: the moderating effects of fear of negative evaluation and past experience. Br J Clin Psychol. 2001;40(Pt 1):23-34. doi:10.1348/014466501163454.
18.Gupta MA, Gupta AK. Psychodermatology: an update. J Am Acad Dermatol. 1996 Jun;34(6):1030-1046. doi:10.1016/s0190-9622(96)90284-4.
19.Rajagopalan M, Inamadar A, Mittal A, Miskeen AK, Srinivas CR, Sardana K, et al. Expert consensus on the management of dermatophytosis in India (ECTODERM India). BMC Dermatol [Internet]. 2018;18(1). Available from: http://dx.doi.org/10.1186/s12895-018-00731
20.Steinhoff M, Dréno B, Rey AB, Morita A. The Skin−Brain Dialogue: Advancing Psychodermatology Through Integrated Approaches. J Eur Acad Dermatol Venereol. 2023;37(4):694-709. doi:10.1111/jdv.18911.
21.Szabó Á, Brodszky V, Rencz F. A comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI‐Relevant and Skindex‐16. Br J Dermatol [Internet]. 2022;186(3):485–95. Available from: http://dx.doi.org/10.1111/bjd.20765
22.Gergely LH, Gáspár K, Brodszky V, Kinyó Á, Szegedi A, Remenyik É, et al. Validity of EQ‐5D‐5L, Skindex‐16, DLQI and DLQI‐R in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol [Internet]. 2020;34(11):2584–92. Available from: http://dx.doi.org/10.1111/jdv.16642.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 American Journal of Psychiatric Rehabilitation
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.
This work is licensed under a 
